Literature DB >> 10722643

Escherichia coli O157:H7 causes more-severe systemic disease in suckling piglets than in colostrum-deprived neonatal piglets.

E A Dean-Nystrom1, J F Pohlenz, H W Moon, A D O'Brien.   

Abstract

Our objective was to determine if suckling neonatal piglets are susceptible to enterohemorrhagic Escherichia coli (EHEC) O157:H7 disease. Surprisingly, EHEC O157:H7 caused more-rapid and more-severe neurological disease in suckling neonates than in those fed an artificial diet. Shiga toxin-negative O157:H7 did not cause neurological disease but colonized and caused attaching-and-effacing intestinal lesions.

Entities:  

Mesh：

Year:  2000        PMID： 10722643      PMCID： PMC97427          DOI： 10.1128/IAI.68.4.2356-2358.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  20 in total

1.  Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987.

Authors:  P I Tarr; M A Neill; C R Clausen; J W Newland; R J Neill; S L Moseley
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

Review 2.  The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.

Authors:  P M Griffin; R V Tauxe
Journal:  Epidemiol Rev       Date:  1991       Impact factor: 6.222

3.  Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets.

Authors:  S Tzipori; C W Chow; H R Powell
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

4.  Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2.

Authors:  A Donohue-Rolfe; I Kondova; J Mukherjee; K Chios; D Hutto; S Tzipori
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

5.  Shiga toxin-producing Escherichia coli infection: temporal and quantitative relationships among colonization, toxin production, and systemic disease.

Authors:  N A Cornick; I Matise; J E Samuel; B T Bosworth; H W Moon
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

6.  Clinical signs and lesions in gnotobiotic pigs inoculated with Shiga-like toxin I from Escherichia coli.

Authors:  S A Dykstra; R A Moxley; B H Janke; E A Nelson; D H Francis
Journal:  Vet Pathol       Date:  1993-09       Impact factor: 2.221

7.  Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.

Authors:  M S Donnenberg; C O Tacket; S P James; G Losonsky; J P Nataro; S S Wasserman; J B Kaper; M M Levine
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model.

Authors:  M S Donnenberg; S Tzipori; M L McKee; A D O'Brien; J Alroy; J B Kaper
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

9.  Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7.

Authors:  D H Francis; R A Moxley; C Y Andraos
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.

Authors:  B Boyd; G Tyrrell; M Maloney; C Gyles; J Brunton; C Lingwood
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307
View more
  18 in total

1.  Host immune status influences the development of attaching and effacing lesions in weaned pigs.

Authors:  Francis Girard; Isabelle P Oswald; Ionélia Taranu; Pierre Hélie; Greg D Appleyard; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.

Authors:  J F Pohlenz; K R Winter; E A Dean-Nystrom
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Bacterial Chat: Intestinal Metabolites and Signals in Host-Microbiota-Pathogen Interactions.

Authors:  Bruna C Lustri; Vanessa Sperandio; Cristiano G Moreira
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

4.  Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.

Authors:  Jean Mukherjee; Kerry Chios; Dianne Fishwild; Deborah Hudson; Susan O'Donnell; Stephen M Rich; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 5.  Role of Shiga/Vero toxins in pathogenesis.

Authors:  Fumiko Obata; Tom Obrig
Journal:  Microbiol Spectr       Date:  2014-06

6.  Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes.

Authors:  Kellie R K Winter; William C Stoffregen; Evelyn A Dean-Nystrom
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection.

Authors:  Evelyn A Dean-Nystrom; Lisa J Gansheroff; Melody Mills; Harley W Moon; Alison D O'Brien
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 8.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 Shiga toxin-producing E coli strains in neonatal pigs.

Authors:  Evelyn A Dean-Nystrom; Angela R Melton-Celsa; Joachim F L Pohlenz; Harley W Moon; Alison D O'Brien
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Transmission and infectious dose of Escherichia coli O157:H7 in swine.

Authors:  N A Cornick; A F Helgerson
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.